Clinical Trials Directory

Trials / Terminated

TerminatedNCT03671005

Mindfulness-based Group Therapy for Inpatients With Schizophrenia Spectrum Disorders

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Charite University, Berlin, Germany · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

A single-centered randomized controlled trial with a parallel-groups design is utilized, comprised of mindfulness-based group therapy (MBGT) in the experimental condition, and treatment as usual (TAU) in the control condition. Participants in the experimental condition continued their regular psychiatric treatment (TAU) next to the participation in the MBGT. In order to evaluate possible psychotherapeutic effects, self-report and other clinical questionnaires including interviews and app-based assessments are evaluated before (T0), and after the four-week intervention (T1). Ward psychiatrists identify eligible participants and invite them to participate in the study. An eligibility screening is held by the study assistant at baseline, introducing the study, providing informed consent in written form, as well as conducting the self-report measures and app-based assessments. A blinded psychiatrist who works independently of the (co-) therapist conducts the remaining rater-questionnaires. Due to the psychotherapeutic nature of the study, information about the treatment allocation had to be shared with the co-therapist and the participants. Randomization was conducted by the Random Group Generator (pubmed, 2018). The data management plan includes standard procedures for data-handling such as using anonymized identification codes for patient data. The participants have the right to access their data, and the right to claim an annihilation. The data is being stored in locked cupboards, only allowing researchers involved in the study to access the data.

Conditions

Interventions

TypeNameDescription
BEHAVIORALMindfulness-based group therapysee above
OTHERTreatment as usualsee above

Timeline

Start date
2018-05-01
Primary completion
2021-02-28
Completion
2021-02-28
First posted
2018-09-14
Last updated
2023-02-09

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03671005. Inclusion in this directory is not an endorsement.